Ablynx NV (STU:4AYB) Price-to-Tangible-Book : 7.83 (As of Jun. 24, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ablynx NV Price-to-Tangible-Book?

As of today (2024-06-24), Ablynx NV's share price is €18.72. Ablynx NV's Tangible Book per Share of Dec. 2017 for the quarter that ended in Dec. 2017 was €2.39. Hence, Ablynx NV's Price to Tangible Book Ratio of today is 7.83.

The historical rank and industry rank for Ablynx NV's Price-to-Tangible-Book or its related term are showing as below:

STU:4AYB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.82 Med: 6.49 Max: 31.63
Current: 18.91

During the past 12 years, Ablynx NV's highest Price to Tangible Book Ratio was 31.63. The lowest was 1.82. And the median was 6.49.

STU:4AYB's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.63 vs STU:4AYB: 18.91

A closely related ratio is called PB Ratio. As of today, Ablynx NV's share price is €18.72. Ablynx NV's Book Value per Sharefor the quarter that ended in Dec. 2017 was €2.41. Hence, Ablynx NV's P/B Ratio of today is 7.78.

Ablynx NV Price-to-Tangible-Book Historical Data

The historical data trend for Ablynx NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Price-to-Tangible-Book Chart

Ablynx NV Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Price-to-Tangible-Book

Get a 7-Day Free Trial

Ablynx NV Semi-Annual Data
	Dec07	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Ablynx NV's Price-to-Tangible-Book

For the Biotechnology subindustry, Ablynx NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ablynx NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ablynx NV's Price-to-Tangible-Book falls into.

Ablynx NV Price-to-Tangible-Book Calculation

Ablynx NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2017 )
	=	18.72	/	2.391
	=	7.83

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Ablynx NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Ablynx NV (STU:4AYB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (STU:4AYB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.ablynx.com

Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (STU:4AYB) Headlines

No Headlines